Clinical Trials Directory

Trials / Completed

CompletedNCT04051762

A Comparative Study Between Postextubation of Preterm Infants Into High-Flow Nasal Cannulae V.S Nasal Continuous Positive Airway Pressure

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ramy Saleh Morsy · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Accepted

Summary

The investigators hypothesize that there is a growing trend of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation mechanism to provide continuous distending pressure to preterm infants. However, there remains uncertainty about the efficacy and safety of HFNC in this population.

Detailed description

Our primary outcome is to determine whether postextubation respiratory support via heated humidified high-flow nasal cannula results in a greater proportion of infants younger than 34 weeks gestation being successfully extubated after a period of endotracheal positive pressure ventilation compared with conventional (NCPAP). The following study will be conducted in the neonatal intensive care unit (NICU) of Gynecology and Obstetric department of Kasr El Aini hospital and neonatal intensive care unit of Military Hospital throughout a time interval of at least 6 months for a minimum of 100 preterm infants. Infants will be eligible for the study if they born at less than 34 weeks' gestation, required endotracheal intubation and positive pressure ventilation, and considered ready for extubation by the clinical team. The investigators will assign extubation of preterm ventilated infants (50 preterm infant) in NICU of Military Hospital into HHFNC and extubation of preterm ventilated infants (50 preterm infant) in (NICU) of Gynecology and Obstetric department of Kasr El Aini hospital into NCPAP (50 preterm infant).

Conditions

Interventions

TypeNameDescription
DEVICEHigh flow nasal cannula vs. Nasal continuous positive airway pressureHigh flow nasal cannula

Timeline

Start date
2017-06-01
Primary completion
2018-05-30
Completion
2018-07-30
First posted
2019-08-09
Last updated
2019-08-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04051762. Inclusion in this directory is not an endorsement.